The human hepatoma cell line, Hep 3B, produces biologically active ery
thropoietin (Epo) in response to normal physiologic stimuli and thus p
rovides a model system for the study of Epo regulation. The addition o
f phorbol 12-myristate 13-acetate (PMA) to Hep 3B cells subsequently g
rown under hypoxic conditions resulted in a dose-dependent inhibition
of hypoxia-induced Epo production by as much as 95 +/- 1% with half-ma
ximal inhibition at 8 ng/mL. By Northern blot analysis, Epo mRNA level
s were correspondingly decreased after treatment with PMA. Direct meas
urement of both membrane and cytosolic protein kinase C activity in He
p 3B cells following treatment with PMA demonstrated a biphasic respon
se as a function of time. Membrane-associated protein kinase C activit
y initially increased but subsequently decreased to baseline levels by
12 hours. The PMA-induced inhibition of hypoxia-induced Epo productio
n was shown to occur as early as 3 hours after PMA addition, suggestin
g that the initial activation, rather than the subsequent decrease in
protein kinase C activity, is of primary importance. The relative spec
ificity of the PMA-induced inhibition of Epo production was demonstrat
ed by 1) the finding that overall protein and RNA synthesis were not s
imilarly decreased as measured by H-3-leucine and H-3-uridine pulse la
beling studies and 2) the observation that the biologically inactive p
horbol ester, 4 alpha-phorbol didecanoate, failed to have any effect o
n hypoxia-induced Epo production. In addition, the synthetic analog of
diacylglycerol, 1-oleoyl-2-acetylglycerol (OAG) and the calcium ionop
hore, A23187, inhibited hypoxia-induced Epo production up to 85 +/- 3%
and 82 +/- 4%, respectively, in a dose-dependent manner. Taken togeth
er, these findings suggest that hypoxia-induced Epo production may be
negatively regulated by activators of a protein kinase C-mediated path
way.